Design Therapeutics, Inc.DSGNNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank33
3Y CAGR-14.0%
5Y CAGR+47.9%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-14.0%/yr
Annual compound
5Y CAGR
+47.9%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
7.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$16.86M-25.3%
2024$22.56M+6.4%
2023$21.20M-20.0%
2022$26.50M-91.1%
2021$298.57M+12450.2%
2020$2.38M+2989.6%
2019$77000.00-